Nephrology

Article	Citations
Update on diagnosis, pathophysiology, and management of diabetic kidney disease	69
Recommendations by the Asian Pacific society of nephrology (APSN) on the appropriate use of HIF‐PH inhibitors	67
Patient‐reported outcome measures ( PROMs): making sense of individual PROM scores and changes in PROM scores over time	45
Appraising prediction research: a guide and meta‐review on bias and applicability assessment using the Prediction model Risk Of Bias ASsessment Tool (PROBAST)	29
Early predictors of acute kidney injury in COVID‐19 patients	26
Peritoneal dialysis first policy in Hong Kong for 35 years: Global impact	22
Humoral and cellular immune response to severe acute respiratory syndrome coronavirus‐2 vaccination in haemodialysis and kidney transplant patients	20
Posters	20
Effects of transient acute kidney injury, persistent acute kidney injury and acute kidney disease on the long‐term renal prognosis after an initial acute kidney injury event	19
Two decades of chronic kidney disease of unknown aetiology (CKDu) research: Existing evidence and persistent gaps from epidemiological studies in Sri Lanka	18
Dietary patterns and chronic kidney disease outcomes: A systematic review	18
Differential expression analysis of urinary exosomal circular RNAs in patients with IgA nephropathy	18
Relapsed ANCA associated vasculitis following Oxford AstraZeneca ChAdOx1‐S COVID‐19 vaccination: A case series of two patients	18
The case for increased peritoneal dialysis utilization in low‐ and lower‐middle‐income countries	17
Improvement of kidney function in patients with chronic kidney disease and severe obesity after bariatric surgery: A systematic review and meta‐analysis	17
Consequences of the first and secondCOVID‐19 wave on kidney transplant recipients at a large Indian transplant centre	16
A working partnership: A review of shared decision‐making in nephrology	16
Gross haematuria after mRNA COVID‐19 vaccination in two patients with histological and clinical diagnosis of IgA nephropathy	15
Personalized immunosuppression after kidney transplantation	15
Gut microbiota, key to unlocking the door of diabetic kidney disease	15
Glomerular hyperfiltration in morbid obesity: Role of the inflammasome signalling	15
Report of two cases of minimal change disease following vaccination for COVID ‐19	14
Sodium‐glucose cotransporter 2 inhibitors for diabetes mellitus control after kidney transplantation: Review of the current evidence	13
Building optimal and sustainable kidney care in low resource settings: The role of healthcare systems	13
A psychosocial intervention for individuals with advanced chronic kidney disease: A feasibility randomized controlled trial	13

Chronic kidney disease is a very significant comorbidity for high risk of death in patients with COVID‐19 in Mexico	13
Peritoneal dialysis: Status report in South and South East Asia	13
An analysis of antibody responses and clinical sequalae of the Sinopharm HB02 COVID19 vaccine in dialysis patients in the United Arab Emirates	12
Sodium‐glucose cotransporter‐2 inhibitors and non‐steroidal mineralocorticoid receptor antagonists: Ushering in a new era of nephroprotection beyond renin‐angiotensin system blockade	12
Demographics and long‐term outcomes of children with end‐stage kidney disease: A 20‐year territory‐wide study	12
Posters	12
Cardiorespiratory fitness assessed by cardiopulmonary exercise testing between different stages of pre‐dialysis chronic kidney disease: A systematic review and meta‐analysis	11
The COVID‐19 pandemic and access to health care in people with chronic kidney disease: A systematic review and meta‐analysis	11
A novel urine cell‐free DNA preservation solution and its application in kidney transplantation	11
Prolonged SARS‐CoV‐2 viral shedding in patients with chronic kidney disease	11
De novo and relapsing glomerulonephritis after COVID‐19 vaccination: how much do we know?	11
Be careful with ecological associations	11
The burden of chronic kidney disease in Asia, 1990–2019: Examination of estimates from global burden of disease 2019 study	11
Levofloxacin based non‐rifampicin anti‐tuberculous therapy: An effective alternative in renal transplant recipients in resource limited setting	10
Nicotiflorin attenuates cell apoptosis in renal ischemia‐reperfusion injury through activating transcription factor 3	10
Serum phosphate and mortality in incident dialysis patients in Australia and New Zealand	10
Trends in the incidence of renal replacement therapy by type of primary kidney disease in Japan, 2006–2020	10
Renal haemodynamic and protective effects of renoactive drugs in type 2 diabetes: Interaction with SGLT2 inhibitors	10
Association and predictive value of geriatric nutritional risk index, body composition, or bone mineral density in haemodialysis patients	10
Mycobacterium tuberculosis peritonitis in peritoneal dialysis patients: A scoping review	9
Exit site infection and peritonitis due to Serratia species in patients receiving peritoneal dialysis: Epidemiology and clinical outcomes	9
Practical considerations for the use of SGLT‐2 inhibitors in the Asia–Pacific countries—An expert consensus statement	9
Dietary interventions on the prevention and management of diabetes in post‐kidney transplantation – A systematic review	9
Active deprescribing program in chronic kidney disease patients undergoing haemodialysis	9
Acute kidney injury associated with COVID‐19—Cumulative evidence and rationale supporting against direct kidney injury (infection)	9
Qualitative research methods and its application in nephrology	9
Predictors of technique failure and mortality on peritoneal dialysis: An analysis of New Zealand peritoneal dialysis registry data	8
MiR‐1297 attenuates high glucose‐induced injury in HK‐2 cells via targeting COL1A2	8
Filtering for the best policy: An economic evaluation of policy options for kidney replacement coverage in the Philippines	8
Commentary on the 2020 update of the KDOQI clinical practice guideline for nutrition in chronic kidney disease	8
Endothelin receptor antagonists in kidney protection for diabetic kidney disease and beyond?	8
The kidney failure risk equation predicts kidney failure: Validation in an Australian cohort	8
Impact of imatinib treatment on renal function in chronic myeloid leukaemia patients	8
Significant association of urinary alpha‐1‐microglobulin compared to urinary neutrophil gelatinase‐associated lipocalin with renal insufficiency in patients with type 2 diabetes	8
Validation of an international prediction model including the Oxford classification in Korean patients with IgA nephropathy	8
Diastolic and systolic left ventricular dysfunction and mortality in chronic kidney disease patients on haemodialysis	8
Changing landscape of dialysis withdrawal in patients with kidney failure: Implications for clinical practice	8
Definitions, phenotypes, and subphenotypes in acute kidney injury—Moving towards precision medicine	8
Aetiology, practice patterns and burden ofend‐stagekidney disease in South Asia andSouth‐EastAsia: A questionnaire‐based survey	8
Financial toxicity experienced by rural Australian families with chronic kidney disease	7
Scutellarin protects the kidney from ischemia/reperfusion injury by targeting Nrf2	7
Bioinformatic investigation for candidate genes and molecular mechanism in the pathogenesis of membranous nephropathy	7
End stage renal disease has an early and continuous detrimental effect on regulatory T cells	7
Effectiveness of integrated care on delaying chronic kidney disease progression in rural communities of Thailand (ESCORT‐2) trials	7
Digital health technologies to support medication adherence in chronic kidney disease	7
Immunoglobulin A nephropathy in paediatrics: An up‐to‐date	7
Acute kidney injury in COVID‐19: Identification of risk factors and potential biomarkers of disease in a large UK cohort	7
Baicalin and baicalein attenuate hyperuricemic nephropathy via inhibiting PI3K/AKT/NF‐κB signalling pathway	7
Recent research progress on the role of ulinastatin in chronic kidney disease	7
Protective effect of small extracellular vesicles (EVs) derived from ACE2‐modified human umbilical cord mesenchymal stem cells against renal ischemia–reperfusion injury	6

Implementation of artificial intelligence Chatbot in peritoneal dialysis nursing care: Experience from a Taiwan medical center	6
COVID‐19 death and kidney disease in a multiracial Asian country	6
Anxiety and psychosocial impact during coronavirus disease 2019 in home dialysis patients	6
Sofosbuvir plus velpatasvir combination for the treatment of chronic hepatitis C in patients with end stage renal disease on renal replacement therapy: A systematic review and meta‐analysis	6
Comparison of hospitalization outcomes for delivery and resource utilization between pregnant women with kidney transplants and chronic kidney disease in the United States	6
Reducingnon‐melanomaskin cancer risk in renal transplant recipients	6
The kinetic estimated glomerular filtration rate ratio predicts acute kidney injury	6
Poster Presentations	6
Perspectives of a proposed patient navigator programme for people with chronic kidney disease in rural communities: Report from national workshops	5
Incremental peritoneal dialysis is a safe and feasible prescription in incident patients with preserved residual kidney function	5
Will advances in functional renal magnetic resonance imaging translate to the nephrology clinic?	5
Impact of phosphate binders on quality of life in dialysis patients: Results from the prospective Dutch nOcturnal and hoME dialysis Study To Improve Clinical Outcomes study	5
Exploring rural and remote patients' experiences of health services for kidney disease in Aotearoa New Zealand: An in‐depth interview study	5
Potential determinants of the E/e′ ratio in non‐dialysis compared with dialysis patients	5
Forkhead box A2‐mediated lncRNA SOX2OT up‐regulation alleviates oxidative stress and apoptosis of renal tubular epithelial cells by promoting SIRT1 expression in diabetic nephrop	5
Clinical factors associated with early and persistent hypocalcaemia after parathyroidectomy in patients on dialysis with severe hyperparathyroidism	5
Traditional medicines prescribed for prevention of COVID‐19: Use with caution	5
A pilot study of anti‐nephrin antibodies in podocytopaties among adults	5
Genetic insight into primary glomerulonephritis	5
The use of virtual physician mentoring to enhance home dialysis knowledge and uptake	5
Misclassification of calcium status in end‐stage kidney disease using albumin‐adjusted calcium levels	5
Lightning Talks	5
Magnetic resonance imaging determination of tissue sodium in patients with chronic kidney disease	5
Acute kidney injury in the tropics	5
Severe hypocalcaemia following denosumab and iron infusion	5
Characteristics of the gastrointestinal microbiota in paired live kidney donors and recipients	5
Histological diagnosis from kidney transplant biopsy can contribute to prediction of graft survival	5
Association between self‐reported appetite and clinical outcomes of peritoneal dialysis patients: Findings from a low middle‐income country	5
Impact of etelcalcetide on fibroblast growth factor‐23 and calciprotein particles in patients with secondary hyperparathyroidism undergoing haemodialysis	5
From MIA to FIFA: The vicious matrix of frailty, inflammation, fluid overload and atherosclerosis in peritoneal dialysis	5
Profile of urinary exosomal microRNAs and their contribution to diabetic kidney disease through a predictive classification model	5
Frequency and risk factors for cognitive dysfunction in peritoneal dialysis patients	4
Renoprotection with sodium‐glucose cotransporter‐2 inhibitors in children: Knowns and unknowns	4
Comparison of kidney transplant outcomes in HLA compatible and incompatible transplantation: A national cohort study	4
Spiritual well‐being and its relationship with patient characteristics and other patient‐reported outcomes in peritoneal dialysis patients: Findings from the PDOPPS	4
The effect of prescribing vitamin D analogues and serum vitamin D status on both contracting COVID‐19 and clinical outcomes in kidney dialysis patients'	4
Safety and efficacy of Oxford vaccine in kidney transplant recipients: A single‐center prospective analysis from India	4
Systematic review and meta‐analysis of potential pleiotropic effects of sevelamer in chronic kidney disease: Beyond phosphate control	4
Muscle power and physical dysfunction: A model for tailoring rehabilitation in chronic kidney disease	4
Late intervention in the remnant kidney model attenuates proteinuria but not glomerular filtration rate decline	4
Association of left ventricular hypertrophy and functional impairment with cardiovascular outcomes and mortality among patients with chronic kidney disease, results from theC‐STRIDEstudy	4
Treatment of chronic active T cell‐mediated rejection after kidney transplantation: A retrospective cohort study of 37 transplants	4
Comparison of skin cancer awareness and sun protection behaviours between renal transplant recipients and patients with glomerular disease treated with immunosuppressants	4
The prevalence of chronic kidney disease in Samoans living in Auckland, New Zealand	4
The need for individualizing teaching and assurance of knowledge transmission to patients training for home dialysis	4
Gender and socioeconomic disparities in global burden of chronic kidney disease due to glomerulonephritis: A global analysis	4
COVID‐19 vaccine acceptance among patients with glomerulonephritis	4
Role of lncRNA‐MEG8/miR‐296‐3p axis in gestational diabetes mellitus	4
Effect of creatinine metrics on outcome after transplantation of marginal donor kidneys	4
Hepatitis B related dilemmas in the renal unit	4
Peptide 17 alleviates early hypertensive renal injury by regulating the Hippo/YAP signalling pathway	3
A new approach to de novo minimal change disease in pregnancy	3
CircHOMER1 aggravates oxidative stress, inflammation and extracellular matrix deposition in high glucose‐induced human mesangial cells	3
The impact of anatomical variables on haemodialysis tunnelled catheter replacement without fluoroscopy	3
Mean of creatinine clearance and urea clearance examined over 1 h estimates glomerular filtration rate accurately and precisely in children	3
Renal involvement in monogenic autoinflammatory diseases: A narrative review	3
Synbiotic supplement for treatment of iron deficiency anaemia in haemodialysis patients: A randomized controlled trial	3
Urinary liver‐type fatty acid binding protein is increased in the early stages of the disease with a risk of acute kidney injury induced by histone	3
Prevalence and risk factors of peripheral artery disease in a population with chronic kidney disease in Australia: A systematic review and meta‐analysis	3
An outpatient model of care for COVID‐19 infected kidney transplant patients – The hospital‐at‐home	3
Pre‐transplant serum Beta Trace Protein indicates risk for post‐transplant major cardiac adverse events	3
Clinical features and outcomes of calciphylaxis in Chinese patients with chronic kidney disease	3
Development of a novel AlphaLISA ImmunoAssay for Big angiotensin‐25	3
Identification of two novel variants of BCS1L gene in a patient with classical GRACILE syndrome	3
High prevalence of Afro‐Caribbean ethnicity and hypoglycaemia in patients with diabetes and end stage renal disease hospitalized with COVID‐19	3
Stroke incidence and chronic kidney disease: A hospital‐based prospective cohort study	3
Assessing urine ammonium concentration by urine osmolal gap in chronic kidney disease	3
	3
The proteinuria‐lowering effects of dapagliflozin are associated with an initial decline in estimated glomerular filtration rate in patients with chronic kidney disease	3
Metformin prevents hypoxia‐induced podocyte injury by regulating the ZEB2/TG2 axis	3
Effects of phosphate binders on bone biomarkers and bone density in haemodialysis patients	3
The Omicron COVID‐19 threat to dialysis patients is dramatically lower than previous variants	3
The relationships among gut microbiota, hypoxia‐inducible factor and anaemia with chronic kidney disease	3
Inpatient and outpatient nephrology management of critically ill patients with acute kidney injury	3
Changes in renal function and predictors affecting renal outcome of living kidney donors: a nationwide prospective cohort study	3
PPAR gamma and PGC‐1alpha activators protect against diabetic nephropathy by suppressing the inflammation and NF‐kappaB activation	3
The efficacy and safety of hydroxychloroquine in pregnant patients with IgA nephropathy: A retrospective cohort study	3
Impact of a kidney‐specific disease‐specific care certification program on the institutional performance indicators of hospitals caring for patients with chronic kidney disease: A national data analys	3
Posters	3
Prospective model for predicting renal recovery in cardiac surgery patients with acute kidney injury requiring renal replacement therapy	3

New‐onset immunoglobulin‐A nephropathy post severe acute respiratory syndrome‐coronavirus‐2 infection indicates rapidly progressive glomerulonephritis	3
Estimating baseline kidney function in hospitalized adults with acute kidney injury	3
Renal graft artery thrombosis following COVID‐19 infection	3
Outcomes of de novo belatacept‐based immunosuppression regimen and avoidance of calcineurin inhibitors in recipients of kidney allografts at higher risk for underutilization	3
Estimating baseline creatinine to detect acute kidney injury in patients with chronic kidney disease	3
Self‐assessment sheet submission rate predicts technique survival in patients initiating peritoneal dialysis	3
Optimal flow volume measurements in forearm versus arm arteriovenous fistulas	3
Adiponectin affects estimated glomerular filtration rate: A two‐sample bidirectional Mendelian randomization study	2
Assessments of right ventricular strain using cardiac magnetic resonance imaging following kidney transplantation	2
Risk factors for progression of chronic kidney disease: An investigation in prepubertal children	2
Mesangial cell‐derived tenascin‐C contributes to mesangial cell proliferation and matrix protein production in IgA nephropathy	2
Management of haemodialysis patients with COVID‐19 in the Omicron BA.4 and BA.5 wave	2
Evaluating the understandability and actionability of online educational videos on pre‐dialysis chronic kidney disease	2
Acute kidney injury referred to the nephrologist: A single centre experience in a tertiary care hospital	2
Mini Orals	2
Novel gain‐of‐function mutation ofTRPC6Q134Pcontributes to late onset focal segmental glomerulosclerosis in a Chinese pedigree	2
Urinary liver‐type fatty acid binding protein is a biomarker reflecting renal damage and the ameliorative effect of drugs at an early stage of histone‐induced acute kidney injury	2
A retrospective database analysis of erythropoiesis‐stimulating agent treatment patterns and associated healthcare resource use in patients with non–dialysis‐dependent chronic kidney disease–related a	2
Chronic kidney disease in public renal practices in Queensland, Australia, 2011–2018	2
Physical functioning in patients with chronic kidney disease stage G3b‐5 in Japan: The reach‐J CKD cohort study	2
Association between estimated GFR and incident hypoglycaemia during hospitalization	2
Two novel variants in a Bardet‐Biedl syndrome type 5 patient with severe renal phenotype	2
A pilot study comparing the efficiency of a novel asymmetric cellulose triacetate (ATA) dialyser membrane (Solacea‐190H) to a standard high flux polysulfone dialyser membrane (	2
Combined effect of obesity and metabolic profile on glomerular dysfunction in hypertensive subjects	2
Gemcitabine‐induced renal thrombotic microangiopathy	2
Renal supportive care programs: An observational study assessing impact on hospitalization and survival outcomes	2
Takayasu's arteritis in a girl with steroid‐dependent nephrotic syndrome: Could rituximab be the culprit?	2
Assessment of frailty and quality of life and their correlation in the haemodialysis population at Palmerston North Hospital, New Zealand	2
Cigarette smoking and adverse health outcomes in patients treated with maintenance dialysis	2
Economics of drug‐coated balloons for arteriovenous fistula stenosis in Japan and Korea based on the IN.PACT AV access trial	2
Global variability of vascular and peritoneal access for chronic dialysis	2
Relationship between sodium removal, hydration and outcomes in peritoneal dialysis patients	2
Oral/oesophageal candidiasis is a risk factor for severe infection after kidney transplantation	2
Dialysis initiation in older persons across centres and over time in Australia and New Zealand	2
Are individual analyses of multiple short urine collections throughout the 24 hours superior to a standard 24‐hour urine collection in precipitation risk assessment of healthy subjects?	2
Infectious complications in adult patients with idiopathic minimal change nephrotic syndrome undergoing immunosuppressive therapy	2
Presence of galectin‐3 in peritoneal dialysate. Does it have a role in the peritoneal membrane inflammatory process?	2
Renal agenesis: A meta‐analysis of its prevalence and clinical characteristics based on 15 641 184 patients	2
A case of severe lactic acidosis in a maintenance haemodialysis patient caused by thiamine deficiency: A case report	2
The successful use of rituximab in crescentic IgA nephropathy with concurrent ANCA positivity	2
Healthcare policy for COVID‐19 patients on haemodialysis: Adapting to the changing needs of the Omicron variant	2
Pregnancy and kidney disease: It is time for the birth of prospective registries	2
Complementary actions of finerenone and SGLT2‐i on renal outcomes?: An urgent need for more information	2
Association between conscientiousness and peritoneal dialysis‐related peritonitis	2
Mini Orals	2
Belatacept in the treatment of acute T‐cell mediated rejection and maintenance immunosuppression in a paediatric kidney transplant recipient	2
A medication frequency error resulting in hypermagnesemia in a patient with kidney failure	2
The first case of peritoneal dialysis‐associated peritonitis due to Lautropia mirabilis	2
Cytomegalovirus tubulo‐glomerulitis and intratubular granuloma: Key histopathological findings in allograft cytomegalovirus infection	2
Avacopan as an additional therapeutic intervention to promote renal recovery in severe ANCA‐associated vasculitis: A case report	2
Constipation and clinical outcomes in peritoneal dialysis: Results from Thailand PDOPPS	2
Impact of variant of concern and vaccination status on COVID‐19 infection virological dynamics in end stage kidney disease patients receiving haemodialysis	2